C

CorMedix
D

CRMD

9.95500
USD
-0.39
(-3.72%)
Market Closed
Volume
15,868
EPS
-0
Div Yield
-
P/E
-12
Market Cap
604,041,566
OverviewSignalsIdeasNews
Related Instruments
    C
    CLDX
    -2.200
    (-8.55%)
    23.530 USD
    C
    CRSP
    0.360
    (0.77%)
    47.280 USD
    C
    CYAD
    0.00000
    (0.00%)
    0.93000 USD
    M
    MDGL
    -13.55
    (-4.48%)
    288.99 USD
    More
News

Title: CorMedix

Sector: Healthcare
Industry: Biotechnology
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets.